Skip to content Skip to navigation

IBM and Illumina Partner on Work to Standardize Genomic Data Interpretation

January 10, 2017
by Heather Landi
| Reprints

IBM Watson Health and Illumina, Inc., a DNA sequencing and array-based technologies company, are partnering with the aim of helping cancer genomics researchers interpret the results of sequences.

As part of the partnership, IBM will integrate Watson for Genomics into Illumina’s BaseSpace Sequence Hub and tumor sequencing process. The collaboration is designed to help standardize and simplify genomic data interpretation. Genome sequencing has increased in recent years following two decades of research demonstrating the promise of precision medicine. However, access to these advances has been limited by the significant time and expense required to interpret the genomic data.

According to an IBM press release, by adding Watson for Genomics to Illumina’s next-generation sequencing platform, researchers who use Illumina’s cancer genome sequencing panel will have rapid access to information to help interpret the broad array of variant data produced by TruSight Tumor 170.  Illumina’s TruSight Tumor 170 is a solid tumor profiling panel designed to detect a comprehensive set of variants across 170 genes.

Through the technology integration, Watson for Genomics will read the genetic alteration files produced by TruSight Tumor 170, comb professional guidelines, medical literature, clinical trials compendia, and other sources of knowledge to provide information for each genomic alteration, and produce a report for use by researchers—a process that typically takes scientists more than one week to complete. Watson for Genomics ingests data from approximately 10,000 scientific articles and 100 new clinical trials every month.

The Watson for Genomics software will be available to support Illumina’s TruSight Tumor 170 assay early in 2017. The Watson service is not yet available for diagnostic use and is for research use only.

 

 

Get the latest information on Healthcare Analytics and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

CMS Extends Deadline for eCQM Data Submission

CMS is extending the deadline for eligible hospitals in the Hospital Inpatient Quality Reporting (IQR) and Meaningful Use programs to submit their electronic clinical quality measure (eCQM) data from 2016.

NorthShore Revalidated by HIMSS Analytics as Stage 7 Worthy

Due to its continued use of IT to improve patient care and reduce costs, Chicago-based NorthShore University HealthSystem has received Stage 7 revalidation on HIMSS’ acute care EMRAM and outpatient EMRAM for its hospitals and associated clinics.

Cybersecurity Consulting Firm CynergisTek Acquired by Auxilio

Austin, Tex.-based cybersecurity and privacy consulting firm CynergisTek has been acquired by Auxilio, Inc., a provider of document workflow solutions and IT security services based in Mission Viejo, California, in a deal valued at up to $34.3 million.

Healthcare Data Breaches: A Year in Review

The latest year-in-review Breach Barometer report from Protenus paints a stark picture—2016 average at least one health data breach per day, affecting more than 27 million patient records.

Healthcare Industry Could Save $9.4B with Full Adoption of Electronic Transactions

The healthcare industry continues to make modest progress toward full adoption of electronic business transactions, but significant gaps remain, representing an opportunity for $9.4 billion in savings, according to new data from the 2016 CAQH Index.

ONC Announces Phase 2 Winners of Consumer, Provider App Challenges

ONC today announced the Phase 2 winners for the Consumer Health Data Aggregator Challenge and the Provider User Experience Challenge.